MedElevator
Войти в исследования International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2010
Molecular Variants of HPV Type 16 E6 Among Honduran Women.
Сравнительное исследованиеСтатьяРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tabora Nelba, Melchers Willem J G, van Doorn Leen-Jan, Quint Wim, Ferrera Annabelle
Аннотация
OBJECTIVE: In this study, we investigated the prevalence of human papillomavirus 16 (HPV-16) variants in Honduran women with normal cytology and with dysplasia and cervical cancer.
METHODS: Samples identified as positive for HPV-16 by SPF10-LiPA were tested for intratypic subtypes and variants by analysis of the E6/E7 region using a novel reverse hybridization assay (line probe assay).
RESULTS: We found that most infections in all clinical groups belong to the E6 European variants, suggesting that HPV-16 non-European variants do not represent an additional factor associated with increased occurrence of high-grade cervical lesions in the studied population. Among the 106 HPV-16-positive women analyzed, E-350G was the most prevalent variant in all different disease stages, being present in 18% of cervical cancer, 13% of cervical intraepithelial neoplasia grade III (CIN III), 5% of CIN II, 5% of CIN I, and 20% of control samples. Mixed variants of HPV-16 infections were detected in 7.7% of the samples, mostly in women with normal cytology.
CONCLUSIONS: This study shows for the first time the diversity of HPV-16 variants in cervical samples of Honduran women.
METHODS: Samples identified as positive for HPV-16 by SPF10-LiPA were tested for intratypic subtypes and variants by analysis of the E6/E7 region using a novel reverse hybridization assay (line probe assay).
RESULTS: We found that most infections in all clinical groups belong to the E6 European variants, suggesting that HPV-16 non-European variants do not represent an additional factor associated with increased occurrence of high-grade cervical lesions in the studied population. Among the 106 HPV-16-positive women analyzed, E-350G was the most prevalent variant in all different disease stages, being present in 18% of cervical cancer, 13% of cervical intraepithelial neoplasia grade III (CIN III), 5% of CIN II, 5% of CIN I, and 20% of control samples. Mixed variants of HPV-16 infections were detected in 7.7% of the samples, mostly in women with normal cytology.
CONCLUSIONS: This study shows for the first time the diversity of HPV-16 variants in cervical samples of Honduran women.
Предметные рубрики MeSH
AdolescentAdultAgedBiomarkers, TumorCase-Control StudiesCervix UteriDNA, ViralDisease ProgressionFemaleGenetic VariationHondurasHumansMiddle AgedNeoplasm StagingOncogene Proteins, ViralPapillomaviridaePapillomavirus InfectionsPrognosisRepressor ProteinsUterine Cervical NeoplasmsYoung AdultUterine Cervical Dysplasia